-
We are the developer of an innovative technology for the production of a completely new highly effective active substance. These regenerating products are extremely effective in treatment of liver cirrhosis of various etiologies previously officially considered incurable (ascites goes away after 15 days, cirrhosis changes into fibrosis after 30-50 days, the period of complete hepatic regeneration is about 4 months). They are also effective against genital herpes virus (4-6 months), effective against hepatitis of various etiologies, including such as B, C, D ( viral load is reduced by half every 26 days, after a course of therapy, the virus is not detected in the blood, the patient ceases to be a virus carrier), drugs restore the liver in case of fatty hepatosis, pulmonary tuberculosis including MDR TB/ XDR TB (after 26 days an active form of stage 4 changes into stage 2-3 of latent form), lymphosarcoma, fibroma, myoma and pyelonephritis. The drugs prevent diabetic foot gangrene extremities. After the therapy patients no longer need previously recommended heart bypass surgery. The drug restores the function of the pancreas, and gives a complete restoration of long-term erectile dysfunction. The condition of patients with Alzheimer disease, Down's syndrome, encephalopathy, encephalitis and other diseases improves significantly without any side effects. The drugs have a strong antifibrotic effect, they dissolve scars on heart after myocardial infarction. Heart tissue completely regenerates within 6 months. This is only what we have studied so far. We have strong assumptions that our medications can also effectively affect the activity of the COVID-19 coronavirus, as well as other viruses and infections. We are interested in partners and research of our drugs.
Consulting / Advisory Services areas: • Big Data Strategy design • Analytics Applications’ roadmap design • Wider Analytics technology infrastructure architectural design and implementation • Analytics’ neighboring domains roadmap design, i.e. Loyalty Scheme design and implementation, Marketing Automation/Campaign Management systems, Mobile Applications’ hosting/integrating technologies, … Professional Implementation Services Generic Analytics Applications & Methodologies: • Value-based Segmentation or/and RFM Analysis • Behavioral Segmentation Analysis • Strategic Segmentation Analysis • Next Best Offer Analysis • Cross/Up/Deep-Selling Propensity Modeling • Early Warnings on Signs of Customers’ Defection Analysis • Anti-Attrition / Churn Propensity Modeling • Social Network Analysis (SNA) • Forecasting Analysis • Credit Risk Modeling (PD, LGD, …) • Pre-Collections & Collections Modeling Industry-specific Analytical Solutions: • Total Enterprise Streamlined Customer Management for Next Best Action (NBA) • Performance Forecasting & Distribution Network Target Allocation • Customer Lending Optimization (CLO) • Geolocation Analytics for Cards’ transactions’ boosting, penetrating loyalty partners’ network (merchants) • Customer “Digitalization” Solution • Customer Onboarding Strategy Solution • Complaints Management via Text Analytics • Streamlined solution for IFRS9 Risk Regulatory Framework compliance and overall processes management.
Turkish Academy of Sciences (TÜBA) has been helping and promoting a Sustainable and Resilient Recovery from COVID-19, as a national science academy of Turkey. TÜBA has also conducted various scientific research from the beginning of the global outbreak. Honor, Principal, and Associate members of TÜBA have taken place in the Scientific Council of Turkey for struggling with COVID-19 and in many different projects related to this pandemic. The main principle of TÜBA is multi-disciplinary and thematic methods in scientific and academic works. To do that, it has promoted the publishing of many generic works in various scientific fields. While we are aware of the global damage of this pandemic, TÜBA started its scientific works for informing people with scientific knowledge in this digitally polluted era. Misinformation in social media and similar channels has negatively affected the struggle with the COVID-19 Pandemic. At this point, TÜBA helped to contribute to reliable data flow through scientific reports, books, and information sharing through social media accounts. Firstly, TÜBA published “The Assessment Report on COVID-19 Global Outbreak” on 17 April 2020. The report has been updated six times periodically in Turkish. The latest version of the report has been translated, published in English, and shared with partner academies without losing time. Transparency and reaching the information have been priorities for our Academy. Secondly, the book namely "Reflections on the Pandemic in the Future of the World" has been published in Turkish and English as the first Post-Corona book in Turkey. There are projections for a wide range of post-epidemic periods, from healthcare to education, information technologies to political science, economics to international relations, trade to Philosophy, artificial intelligence studies, sociological analysis, Environment and agriculture, space, and polar studies. Thirdly, “TÜBA Report on Climate Change and Public Health in Turkey” has been published in Turkish and English. It has comprehensively analyzed the situation of Turkey and in vital areas such as Sustainable Development, Climate Change, and Public Health. Fourthly, “TÜBA COVID 19 – Global Outbreak: Report on Judicial Changes and Interactions” has been published in Turkish and English. The report analyses the effects of the COVID–19 Outbreak on Constitutional Law, Administrative Law, Penal Law, Tax Law, International Law, Civil Law, Commercial Law, Labor and Social Security Law, Enforcement and Bankruptcy Law in five chapters. All these reports and books were prepared with help of the following scientific experts including experts from TÜBA, Working Groups of Academy such as Cancer, Food and Nutrition and Sustainable Development, Finance and Environment Working Group, TÜBA Young Academy, and Coronavirus Scientific Committee. Scientists and academicians worked together on these reports for ensuring to receive clear and accurate information about the pandemic in Turkey.